Ctrl

K

Ketotifen

Class
Antihistamines
Subclass
First-generation H1-antihistamines
Generic name
Ketotifen
Common formulations
Ophthalmic solution
Dosage and administration
Adults patients
Treatment of red eyes
•
1 gtt OPHTH BID-TID
Indications for use
Labeled indications
Adults
•
Treatment of allergic conjunctivitis
•
Treatment of red eyes
Children
•
Treatment of red eyes
Safety risks
Contraindications
Wearing contaminated or damaged lenses
Any corneal or ocular infection, decreased corneal sensation, or ocular hyperemia
Pre-existing corneal abrasion, corneal ulceration, dry eye disease, or injury/abnormality that affects the eyelids or anterior segment of the eye
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
•
Use acceptable. No dose adjustment required.
Renal replacement therapy
Any modality
•
Use acceptable. No dose adjustment required.
Hepatic impairment
Any severity
•
Use acceptable. No dose adjustment required.
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: B1
•
Use only if benefits outweigh potential risks. Evidence of fetal harm in animals. Caution is recommended.
•
This drug should be used during pregnancy only if the benefit to the mother outweighs the risk to the fetus.
Breastfeeding
Acceptable for use during breastfeeding.
•
Intraocular formulation only.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Very common > 10%
•
Conjunctival injection, headache, rhinitis
Common 1-10%
•
Conjunctivitis, hyperlacrimation, keratitis, mydriasis, pharyngitis, eye pain, generalized pruritus, photophobia, red eyes, skin rash, xerophthalmia
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource